The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.
- Authors
- Moore, Elizabeth; Mancuso, Serafino G; Slade, Tim; Galletly, Cherrie; Castle, David J
- Year
- 2012
- Journal
- The Australian and New Zealand journal of psychiatry
- PMID
- 22472772
- DOI
- 10.1177/0004867412443900
OBJECTIVE: To provide the most up-to-date prevalence estimates of alcohol and illicit drug use among individuals with psychosis in Australia, and explore correlates associated with a lifetime diagnosis of both alcohol abuse/dependence and cannabis abuse/dependence. METHOD: This paper uses data from the Survey of High Impact Psychosis (SHIP), conducted as a follow-up to the first Australian National Low Prevalence (Psychotic) Disorders Study (1997-1998). The SHIP was a national study, carried out across five states, in which a sample of 1825 individuals was recruited through a two-phase sampling framework. RESULTS: Alcohol and illicit drug use was highly prevalent for the entire sample. There were few significant differences in the prevalence or frequency of use across the diagnostic categories examined. Substantial increases in substance abuse/dependence were noted since the 1997-1998 survey (51% diagnosed with alcohol abuse/dependence, 51% with cannabis abuse/dependence and 32% with other illicit drug abuse/dependence, compared to 28%, 23% and 12% respectively, in the 1997-1998 survey by Kavanagh et al., 2004). Factors significantly associated with both lifetime alcohol and cannabis dependence included male gender, younger age, single marital status, lower educational attainment, shorter duration of illness, lifetime presence of hallucinations, higher negative syndrome score and lower body mass index (BMI). A number of other factors were found to be differentially associated with either lifetime alcohol or cannabis dependence. CONCLUSIONS: The use of alcohol and illicit substances is common among people with a psychotic illness, with a concerning upward trend in rates of substance abuse/dependence since the 1997-1998 survey. Clinicians should be aware of the potential impact of concurrent substance use and provide integrated treatment for individuals presenting with psychotic illnesses. More research and investment in new intervention programs is required.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Comorbidity of severe psychotic disorders with measures of substance use. | 2014 | 24382686 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Risks for re-hospitalization of persons with severe mental illness living in rehabilitation care settings. | Nisim U et al. | — | 2024 | → |
| A retrospective study of a national survey of persons with severe mental illness living in rehabilitation care settings: Risks for re-hospitalization | Nisim U et al. | — | 2023 | — |
| Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data. | Patel R et al. | — | 2023 | → |
| Ageing with psychosis - Fifty and beyond. | Galletly C et al. | — | 2022 | → |
| Behavioral Interventions to Reduce Cardiovascular Risk Among People with Severe Mental Disorder. | Baker AL et al. | — | 2022 | → |
| Evaluating schizotypy and alcohol usage as predictors of increased engagement in risky sexual behaviors in an undergraduate sample. | Cartier ML et al. | — | 2022 | → |
| Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review. | Coles AS et al. | — | 2021 | → |
| Prevalence and Demographic Correlates of Substance Use among Adults with Mental Illness in Eastern Cape, South Africa: A Cross-Sectional Study. | Tindimwebwa L et al. | — | 2021 | → |
| Prevalence of Severe Mental Illness Dual Diagnosis Among Inpatients in a Psychiatric Hospital in Malaysia. | Subramaniam S et al. | — | 2021 | → |
| Problematic Drug Use Among Outpatients With Schizophrenia and Related Psychoses. | Chang S et al. | — | 2021 | → |
| The association between sleep quality and attenuated psychotic symptoms. | Clarke S et al. | — | 2021 | → |
| Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis. | Schifani C et al. | — | 2020 | → |
| Supporting the vulnerable: developing a strategic community mental health response to the COVID-19 pandemic. | Thomson S et al. | — | 2020 | → |
| Psychosocial Factors Affecting Smoking Cessation Among People Living With Schizophrenia: A Lived Experience Lens. | Cocks N et al. | — | 2019 | → |
| Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics. | Schaffer AL et al. | — | 2019 | → |
| Addiction Vulnerability: Exploring Relationships Among Cigarette Smoking, Substance Misuse, and Early Psychosis. | Clark V et al. | — | 2018 | → |
| Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review. | Arranz B et al. | — | 2018 | → |
| Counting up the risks: How common are risk factors for morbidity and mortality in young people with psychosis? | Hahn LA et al. | — | 2018 | → |
| Holistic Management of Schizophrenia Symptoms Using Pharmacological and Non-pharmacological Treatment. | Ganguly P et al. | — | 2018 | → |
| Impact of substance use disorder on gray matter volume in schizophrenia. | Quinn M et al. | — | 2018 | → |
| Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort. | Colizzi M et al. | — | 2018 | → |
| Multivariate Associations Among Behavioral, Clinical, and Multimodal Imaging Phenotypes in Patients With Psychosis. | Moser DA et al. | — | 2018 | → |
| Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis. | Hunt GE et al. | — | 2018 | → |
| Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines. | Preuss UW et al. | — | 2018 | → |
| Who should be "controls" in studies on the neurobiology of psychiatric disorders? | Boksa P et al. | — | 2018 | → |
| Men and women with psychosis and the impact of illness-duration on sex-differences: The second Australian national survey of psychosis. | Hanlon MC et al. | — | 2017 | → |
| Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis. | Morgan VA et al. | — | 2017 | → |
| Royal Australian and New Zealand College of Psychiatrists expert consensus statement for the treatment, management and monitoring of the physical health of people with an enduring psychotic illness. | Lambert TJ et al. | — | 2017 | → |
| Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study. | Schoeler T et al. | — | 2016 | → |
| Obstructive sleep apnea and schizophrenia: A systematic review to inform clinical practice. | Myles H et al. | — | 2016 | → |
| Pharmacological treatment of schizophrenia with comorbid substance use disorder. | Azorin JM et al. | — | 2016 | → |
| Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report. | Tucker MG et al. | — | 2016 | → |
| Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study. | Toftdahl NG et al. | — | 2016 | → |
| Reducing smoking reduces suicidality among individuals with psychosis: Complementary outcomes from a Healthy Lifestyles intervention study. | Sankaranarayanan A et al. | — | 2016 | → |
| Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. | Galletly C et al. | — | 2016 | → |
| Stopping the run-around? A study of services for people with comorbid mental health and substance use disorders in northern Adelaide. | Cairney I et al. | — | 2015 | → |
| The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. | van Amsterdam J et al. | — | 2015 | → |
| Comorbidity of severe psychotic disorders with measures of substance use. | Hartz SM et al. | — | 2014 | → |
| Gone to Pot - A Review of the Association between Cannabis and Psychosis. | Radhakrishnan R et al. | — | 2014 | → |
| Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample. | Sara GE et al. | — | 2014 | → |
| Ten-year audit of clients presenting to a specialised service for young people experiencing or at increased risk for psychosis. | Conrad AM et al. | — | 2014 | → |
| Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend. | Stefanis NC et al. | — | 2013 | → |
| Behavioral interventions for antipsychotic induced appetite changes. | Werneke U et al. | — | 2013 | → |
| Cannabis and psychosis: what causes what? | Castle DJ | — | 2013 | → |
| Where to for Australian mental health services? Promoting self-efficacy. | Castle DJ | — | 2013 | → |
| Is Australian psychiatry getting SHIP shape? | Berk M | — | 2012 | → |
| Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis. | Cooper J et al. | — | 2012 | → |